Kris Verburgh
AeroLeads people directory · profile

Kris Verburgh Email & Phone Number

General Partner and Head of Science at BOLD Longevity Growth Fund
Location: London, England, United Kingdom 11 work roles 3 schools
1 work email found @blg.vc LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email k****@blg.vc
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
General Partner and Head of Science
Location
London, England, United Kingdom
Company size

Who is Kris Verburgh? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Kris Verburgh is listed as General Partner and Head of Science at BOLD Longevity Growth Fund, a with 13 employees, based in London, England, United Kingdom. AeroLeads shows a work email signal at blg.vc and a matched LinkedIn profile for Kris Verburgh.

Kris Verburgh previously worked as General Partner & Head of Science at Bold Longevity Growth Fund and Expert - Medicine, Biotech and Longevity at Singularity University. Kris Verburgh holds Research (New Developments In Medicine, Biotechnology And Longevity) from Vrije Universiteit Brussel.

Company email context

Email format at BOLD Longevity Growth Fund

This section adds company-level context without repeating Kris Verburgh's masked contact details.

*@blg.vc
71% confidence

AeroLeads found 1 current-domain work email signal for Kris Verburgh. Compare company email patterns before reaching out.

Profile bio

About Kris Verburgh

Medical doctor, researcher, inventor, investor and author with deep expertise in aging/longevity and new trends, developments and paradigm shifts in medicine and biotechnology - which new technologies will disrupt medicine, health(care) and our lifespan? Main medical focus on aging (biogerontology), metabolism (diabetes, cardiovascular disease, neurodegenerative diseases, obesity), preventive medicine, and neuroscience (including brain health/brain aging). Main biotechnological focus on novel technologies, such as gene editing, transcriptomics, epigenetics, AI, drug discovery, and many others.Partner and Head of Science at Bold Longevity Growth (BLG) Fund, which invests in the latest (bio)technologies to slow down aging. Verburgh was Partner and Head of Science at Longevity Vision Fund (LVF), a $100 million fund that invested in longevity (bio)technologies to slow down aging. LVF is closed for new investments. The successor of LVF is the Bold Longevity Growth Fund. Co-founded NOVOS, the first science-based nutraceutical to address 9 important hallmarks of aging. Verburgh wrote his first science book at the age of 16 and 4 books by the age of 28. One 520-page book uses scientific insights from biology, physics, mathematics and chemistry to addresses philosophical questions. His most recent book "The Longevity Code" explains how nutrition and new biotechnologies can slow down aging and improve health. “Dr. Verburgh tackles age-old questions and arrives at some startling conclusions – with practical suggestions for how to slow down our biological clock.”- Professor David Ludwig, Harvard University and Harvard Medical School, about "The Longevity Code"Expertise and interests: • New trends and developments in medicine, biotechnology and healthcare• Biogerontology, aging and aging-related diseases (including new biotechnologies and drugs to slow aging and treat aging-related diseases; nutrition to slow down aging - created a new field called "nutrigerontology" (Aging Cell, 2014); etc.)• Preventive, personalized and predictive medicine and longevity medicine• Neuroscience, including neuroesthetics, origins of creativity and intelligence, neurobiological roots of morality and religion (university master dissertation).More information on www.krisverburgh.com

Listed skills include Science, Neuroscience, Research, Medicine, and 21 others.

Current workplace

Kris Verburgh's current company

Company context helps verify the profile and gives searchers a useful next step.

BOLD Longevity Growth Fund
Bold Longevity Growth Fund
General Partner and Head of Science
London, GB
Website
Employees
13
AeroLeads page
11 roles · 13 years

Kris Verburgh work experience

A career timeline built from the work history available for this profile.

General Partner & Head Of Science

Current

Boston, Ma, Us

BOLD Longevity Growth is a leading global longevity and biotechnology fund investing in frontier therapies and technologies to treat the root causes of disease and extend healthy human lifespan. The fund specializes in the growth and scaling stages at the intersection of longevity, biotech, and artificial intelligence with a mission to make those technologies affordable and accessible for everyone.More info: www.blg.vc

Sep 2023 - Present

Expert - Medicine, Biotech And Longevity

Current

Mountain View , California , Us

Expert in new developments in medicine, biotechnology, and longevity.Kris Verburgh is a Singularity University Expert for The Future of Medicine, Biotechnology and Longevity, teaching companies, organizations and leaders about new breakthroughs enabling us to live healthier, longer lives. Singularity University educates, inspires, and empowers leaders to apply exponential technologies to address humanity's grand challenges. Singularity University is a global community using exponential technologies like artificial intelligence, robotics, and digital biology to tackle the world’s biggest challenges. With its community of entrepreneurs, corporations, development organizations, governments, investors, and academic institutions, it has the necessary ingredients to create a more abundant future for all.https://www.su.org/experts/kris-verburgh

Oct 2016 - Present

Scientific Researcher - Future Of Medicine And Longevity

Current

Brussel, Be

Dr. Verburgh’s research interests are the aging process (biogerontology), aging-related diseases (Alzheimer's disease, cardiovascular disease, cancer, osteoporosis, etc.), metabolism, preventive medicine, and nutrition.He researches how low-tech interventions (nutrition, exercise, sleep, ...) and high-tech interventions (new biotechnologies) can slow down aging, extend (healthy) lifespan and reduce the risk of aging-related diseases like cardiovascular disease, neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, vascular dementia, …), sarcopenia (muscle loss), macular degeneration, osteoporosis, etc.He examines how insights from the biogerontological field can be used to assess and predict the efficacy of dietary, medical and biotechnological interventions aimed at reducing the risk of aging-related diseases and increasing healthy lifespan.In addition, Verburgh has a keen interest in evolution, the origin and complexity of life, and neuroscience (consciousness, neurotheology, neuroesthetics, theory of mind and the origins of creativity) and has written several books on those subjects.

2014 - Present ~12 yrs 6 mos

Member Evolution, Complexity And Cognition Group (Ecco)

Current

Brussel, Be

The Evolution, Complexity and Cognition group is a multidisciplinary research group, directed by professor Francis Heylighen at the Vrije Universiteit Brussel (VUB). It's philosophy is intrinsically transdisciplinary, transcending the traditional boundaries between "hard" and "soft" sciences, and between philosophical foundations and practical applications. Our research focuses on emergence and evolution. Examples of such processes include the emergence of life from molecules, organisms from cells, ecosystems from interacting organisms or the mind from neurons.

2014 - Present ~12 yrs 6 mos

Medical Doctor (Md)

Current
Consultations & Longevity Concierge Services

Consultations on preventive medicine, longevity, and optimal health, ranging from nutrition and supplements to latest biotechnologies and medtech to improve healthspan and lifespan.More info on www.krisverburgh.com

Oct 2011 - Present

Speaker / Panelist

Current

Rotterdam, Nl

Lectures on aging, health, medicine, neuroscience, evolution and other subjects. Dr. Verburgh has given lectures for: - Cambridge University (Cambridge, UK)- King's College (London, UK)- Profil Institute of Metabolic Research (Neuss, Germany) - University of Maastricht (Netherlands)- University of Nijmegen (Netherlands)- National Obesitas Conference (Netherlands)- Eurosymposium on Healthy Ageing (EHA) (Brussels, Belgium)- European Parliament / Heinrich-Böll Foundation (Brussels, Belgium)- Mensa- Rotary- Martinair- SAP- ESTEC (European Space Research and Technology Centre)- And many other organisations and institutions. "There are speakers who reach the ears of their audience and there are speakers who reach ears and heart. Kris Verburgh is one of the latter and enchanted everybody." Peter van Lindonk, co-Founder & director PINC (People, Ideas, Nature and Creativity) Conferences

Nov 2004 - Present

Author

Current

New York, New York, Us

Dr Verburgh is the author of 4 books about science, health and aging. He wrote his first book at the age of 16. Some of his books sold more than 400,000 copies.

Oct 2003 - Present

Partner & Head Of Science

New York, New York, Us

Longevity Vision Fund (LVF) is one of the first and largest longevity-focused funds in the world. LVF's portfolio consists of pioneering companies developing novel technologies such as gene editing, gene therapies, transcriptomic drugs, epigenetic therapies, AI, regenerative medicine, etc. to treat aging-related diseases and extend healthy lifespan.The ultimate goal of the fund is the help develop technologies, products and services that significantly expand human health and lifespan.LVF is closed for new investments. A new fund, following LVF, is BOLD Longevity Growth Fund, of which Verburgh is currently Partner and Head of Science.

Mar 2019 - Aug 2023

Co-Founder

New York, Ny, Us

NOVOS develops science-based nutraceuticals to slow down aging. NOVOS Core is the only nutraceutical targeting 9 important hallmarks of aging, created with some of the most esteemed scientists from Harvard University, MIT, Salk Institute and others, including Professor George Church from Harvard University. “The NOVOS formulation is informed by science and is the current state-of-the-art in longevity supplements.”– Dr. Joao Pedro de Magalhaes, PhD, Harvard Medical School Postdoc, Professor at the Institute of Aging and Chronic Disease, University of Liverpool“What really impressed me about NOVOS was both the comprehensiveness of their analysis of aging research to design their product and their acknowledgment that aging is a complex process that is very unlikely to be successfully addressed with a single compound.”– Dr. Pamela Maher, PhD, Salk Institute for Biological StudiesMore info on www.NovosLabs.com

Jun 2019 - Jul 2023

Member Advisory Board 'Voeding Leeft'​ ('Nutrition Lives'​)

Amsterdam, Noord Holland , Nl

'Voeding Leeft' is an independent organization of dietitians, medical doctors, scientists and professors who want to create more awareness about the importance of nutrition for the prevention and treatment of obesity, metabolic diseases and aging-related diseases like cardiovascular disease and type 2 diabetes.

Oct 2015 - Jun 2018
3 education records

Kris Verburgh education

Research (New Developments In Medicine, Biotechnology And Longevity)

Vrije Universiteit Brussel

Medicine

University Of Antwerp

Science And Mathematics

Sint-Jan Berchmans Institute
FAQ

Frequently asked questions about Kris Verburgh

Quick answers generated from the profile data available on this page.

What company does Kris Verburgh work for?

Kris Verburgh works for BOLD Longevity Growth Fund.

What is Kris Verburgh's role at BOLD Longevity Growth Fund?

Kris Verburgh is listed as General Partner and Head of Science at BOLD Longevity Growth Fund.

What is Kris Verburgh's email address?

AeroLeads has found 1 work email signal at @blg.vc for Kris Verburgh at BOLD Longevity Growth Fund.

Where is Kris Verburgh based?

Kris Verburgh is based in London, England, United Kingdom while working with BOLD Longevity Growth Fund.

What companies has Kris Verburgh worked for?

Kris Verburgh has worked for Bold Longevity Growth Fund, Singularity University, Vrije Universiteit Brussel, Consultations & Longevity Concierge Services, and Speakers Academy®.

How can I contact Kris Verburgh?

You can use AeroLeads to view verified contact signals for Kris Verburgh at BOLD Longevity Growth Fund, including work email, phone, and LinkedIn data when available.

What schools did Kris Verburgh attend?

Kris Verburgh holds Research (New Developments In Medicine, Biotechnology And Longevity) from Vrije Universiteit Brussel.

What skills is Kris Verburgh known for?

Kris Verburgh is listed with skills including Science, Neuroscience, Research, Medicine, Public Speaking, Biotechnology, Teaching, and Lifesciences.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.